Epidemiological studies suggest that a moderate consumption of anthocyanins may be associated with protection against coronary heart disease. The main dietary sources of anthocyanins include red-coloured fruits and red wine.
Furthermore urine was collected during this 24h period. Anthocyanins were detected in their intact form in both plasma and urine samples. Other anthocyanin metabolites could also be detected in plasma and urine and were identified as glucuronides of peonidin and malvidin. Anthocyanins and their metabolites appeared in plasma about 30 minutes after ingestion of the test meal and reached their maximum value around 1.6 hours later for glucosides and 2.5 hours for glucuronides. Total urinary excretion of red wine anthocyanins was 0.05 ± 0.01% of the administered dose within 24 hours. About 94 % of the excreted anthocyanins were found in urine within 6 hours. In spite of the low concentration
INTRODUCTION
Anthocyanins are a group of natural occurring pigments responsible for the redblue colour of many fruits and vegetables. They are glycosides of the anthocyanidins which consist of various polyhydroxy or polymethoxy derivates of 2-phenylbenzopyrylium or flavilium salts [1] . The intake of anthocyanins in humans, mainly ingested in the form of cyanidin derivatives from fruits and malvidin and related compounds from red wine, has been estimated to be between 12 and 215 mg/day [2] [3] [4] which is higher than other flavonoids including quercetin, kaempferol, myricetin, apigenin, and luteolin [5] . The main sources of anthocyanins in the human diet are to be found in many red-coloured fruits, such as black currants, blueberries, red plums or cherries, cereals and vegetables, as well as in wine. Additionally, there is an increasing interest in the use of this group of natural colorants as food additives due to the negative attitude of consumers towards artificial alternatives. This growing use of anthocyanins in the food industry is likely to result in an increase in overall population consumption.
However anthocyanin bioavailability is low with < 1% absorption of the ingested dose. Following absorption they appear in the blood and urine as glycosilated, methylated, glucuro-and/or sulfoconjugate forms. The recovery of anthocyanins and anthocyanins metabolites in urine has been estimated to be between 0.004 and 0.11% of dose [6] . However most of the available data on anthocyanin bioavailability is based on studies carried out examining the metabolism of 4 cyanidin derivatives, from black currant or elderberry, pelargonidin glycosides from strawberries and delphinidin glycosides from blueberries. To date there is little information available on the absorption and subsequent metabolism and excretion of malvidin and other red wine/grape anthocyanidins which are main contributors to the total anthocyanin intake in Mediterranean countries.
Epidemiological evidences as wells as in vitro and animal studies suggest that a moderate consumption of these anthocyanins may be associated with protection against cardiovascular diseases [7] [8] , chronic inflammation [9] , and cancer [10] .
Anthocyanins exhibit moderate free radical scavenging activity and have been shown to decrease tumour necrosis factor-alpha (TNF-)-induced monocyte chemoattractant protein (MCP-1) production in cultured endothelial cells and endothelioma cells [7, [9] [10] . MCP-1 is a CC chemokine shown to in part mediate the recruitment of macrophages to sites of infection or inflammation sites.
Therefore the role of anthocyanidins as antioxidants and regulators of MCP-1 expression are likely to make a significant contribution to their anti-atherogenic effects.
However, in vivo data regarding the effect of red wine anthocyanins on MCP-1 levels in humans are missing. Furthermore it is unclear if and to what extend red wine anthocyanins may affect the antioxidant capacity of human plasma. Thus, the objective of the present work was to study the bioavailability of red grape anthocyanins and to clarify the effect of their consumption on both plasma antioxidant status and MCP-1 concentrations.
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METHODS AND MATERIALS
Materials.
All reagents were obtained from Sigma Aldrich (Madrid, Spain) unless otherwise stated and were of analytical or HPLC grade where applicable. Water was purified via a Milli Q plus system (Millipore, Bedford, MA). Enocianin (E-163), a Vitis vinifera grape peel anthocyanidin-rich extract, was kindly supplied by Sensient Food Colors Italy (Reggio Emilia, Italy). The 3-glucosides of pelargonidin, delphinidin, cyanidin, petunidin, peonidin and malvidin used as external standards were from Polyphenols AS (Sandnes, Norway).
Chemical characterization of the anthocyanin extract
All analyses were carried out using a Hewlett-Packard Agilent 1100 Series liquid chromatograph with a quaternary pump and photodiode array detector. The HPLC system was equipped with a Phenomenex Aqua C18 column (5 µm; 200 Å; 4.6 x 150mm) which was set thermostatically at 35° C. Solvents used were aqueous 0.1% trifluoracetic acid (A) and HPLC-grade acetonitrile (B) at a flow rate of 0.5 mL/min. Starting isocratically with 10% B up to 20 min the gradient was 13% B from 20 to 35 min, 15% B from 35 to 55 min, 35% B from 55 to 65 min and 10%
B from 65 to 70 min. Detection wavelengths were 280, 360 and 520 nm.
Analyses were carried out in triplicate.
MS spectrometry was performed using a Finningan LCQ equipped with API surface, using an electrospray ionization (ESI) interface. The HPLC system was connected to the mass spectrometer probe via the diode array detector cell outlet using polyethyletherketone (PEEK) tubing. Both the auxiliary and the sheath gas 6 were a mixture of nitrogen and helium at flow rates of 1.2 and 6 L/min respectively. The capillary temperature was 195ºC and the capillary voltage was 4 V. The MS detector was programmed to perform a series of three consecutive scans: a full scan from 120 to 1500 amu, an MS Total anthocyanins in the grape extract were quantified at 520 nm as malvidin-3-glucoside by integrating all the peaks. The concentration of 3-monoglucosides of delphinidin, cyanidin, petunidin, peonidin and malvidin in the sample was determined using commercially available standards.
Human study.
Human subjects: Seven healthy subjects were asked to participate in the study. 
Plasma analysis.
For determination of the pharmacokinetic profile of anthocyanins, plasma samples were analysed by HPLC-DAD-MS after solid phase extraction using SPE C18
cartridges. Pelargonidin-3-glucoside (35 pmol in 0.44 mM TFA), used as the internal standard, was added to acidified plasma samples (0.65 mL).
Anthocyanins and their metabolites were extracted from plasma samples by using an octadecylsilane cartridge (Sep-pack C18, Waters, Massachussets, USA). Prior to sample elution, the solid phase cartridge was equilibrated with 7 mL methanol and then 7 mL 0.1 % TFA. Once the acidified plasma sample was deposited in the cartridge a first wash was done by eluting 7 mL of 0.1 % TFA. 
Urine analysis.
Urine samples were analysed by HPLC-DAD-MS after solid phase extraction using SPE C18 cartridges. 0.17 mL HCl were added to 10 mL urine together with the internal standard, pelargonidin-3-glucoside (1.4 nmol in 0.44 mM TFA).
Anthocyanins and their metabolites were extracted from urine samples by using the same procedure as that used for the plasma samples themselves, but with the exception that the final elution was carried out with 2 mL methanol:0.44 TFA in water (75:25,v:v). The supernatant (100 µL) was directly injected into the HPLC-DAD-MS system under the same conditions as those for plasma samples. The method was optimized and % recoveries of 90 ± 8, 73 ± 4, 84 ± 4, 70 ± 5 and 100 ± 9 % respectively were observed for the 3-monoglucosides of delphinidin, cyanidin, petunidin, peonidin and malvidin. Inter-assay precision was determined in the same way as for plasma samples and showed a variation coefficient of 9 %. 11 Good linearity for the assay (r 2 > 0.993) was found over the investigated calibration range of 1-1000 ng/mL for all the anthocyanins.
Ferric reducing ability of plasma (FRAP)
The FRAP assay was performed as previously described (11) . FRAP reagent was 
Trolox equivalent antioxidant capacity (TEAC)
Sixteen hours prior to the assay being performed, the ABTS radical was prepared by adding 5 mL of a 4.9 mM potassium persulfate solution to 5 ml of a 14 mM ABTS solution (11) . This solution was diluted in distilled water to yield an absorbance of 0.70 at 734 nm (Perkin Elmer UV/Vis Lambda Bio 20). The final reaction mixture contained 10 µL of standard or plasma in a 1 mL ABTS solution.
The samples were vortexed for 10 s, and 6 min after the addition the absorbance at 734 nm was recorded and compared to the ABTS radical solution plus distilled water. A standard curve was obtained by using Trolox as an internal standard (range: 0-100 µM). TEAC values express the µmols of Trolox equivalent to the antioxidant capacity of a 1.0 µmol solution of the test substance (12) .
Monocyte chemoattractant protein 1 (MCP-1).
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The levels of MCP-1 in plasma were measured by using a commercially available ELISA kit (R D Systems Europe, Abingdon, UK.). Sera were diluted 1 in 3 for the quantification of MCP-1. The concentration of this molecule was calculated with reference to a standard curve performed with the corresponding recombinant molecule. All serum samples were tested in duplicate.
Pharmacokinetic and statistical analysis.
Curves were generated for each subject using a one-compartment model. The maximum plasma concentration (C max ), and the time taken to reach maximum plasma concentration (t max ) were calculated from the observed values. The AUC from 0 to 24 hours were calculated by the linear trapezoidal method. The elimination rate constant (k el ) was calculated by using the formula Ct = C 0 x e- 
RESULTS
Characterization of the anthocyanin extract
Absorption of anthocyanins: plasma levels
No anthocyanins were evident in the baseline plasma samples of the seven participants. After ingestion of the anthocyanin extract the malvidin and peonidin monoglucosides, as well as their glucuronides, could be detected and quantified in the plasma. The 3-monoglucosides of delphinidin and petunidin could be detected but were under the detection limit to allow accurate quantification. No detectable cyanidin-3-glucoside was present in any of the plasma samples collected follow anthocyanin administration. Figure 1 shows the kinetics of appearance of the different quantified pigments in the plasma over the study period (24 hours). The large errors bars demonstrate considerable inter-individual variations in the levels detected. In the case of the malvidin and peonidin glucuronides the large SD are in part due to the lack of detection of these metabolites in the plasma of two of the subjects participating in the study. As will be discussed later these same subjects presented very low levels of malvidin-glucuronide in their urine (< 5 μg). Table 1 shows plasma kinetic parameters of the quantified pigments. The average time required to reach maximum plasma concentration (t max ) for the glucosides was found to be 1.6 h. This is in agreement with published data where averages times were 1.5 h when anthocyanins are ingested together with solid foods as in our study [13] . Glucuronides reached their maximum concentration over a longer period of, around 2.3 h. thus indicating that anthocyanin 14 glucuronidation may take place, at least to some extent, in the liver. In general, the rapidity with which anthocyanins appear in the plasma may be explained by their ability to permeate the gastric mucosa as shown by Passamonti et al. [14] in a rat model.
Maximum plasma concentrations (C max ) reached after anthocyanin consumption corresponded with those described in other bioavailability studies using similar anthocyanin doses [15] . In the present work, following ingestion of 90 mg malvidin-3-glucoside, the average maximum plasma levels reached were 4.2 ± 1.3 nM in its intact form and 1.2 ± 0.9 nM as its conjugate metabolite with glucuronic acid. ); with the AUC for 15 the total of peonidin metabolites three times higher than that of malvidin and its metabolite.
In every case anthocyanins presented short half-lives. Glucuronic acid conjugates of the anthocyanins showed half-lives of 2.0 ± 1.1 and 1.3 ± 0.7 h for peonidin and malvidin glucuronides respectively. Again, anthocyanin half-lives showed large interindividual variations. The maximum variability was that of peonidin glucoside with a variation coefficient of 67.6 %, and half-life values of between 0.9 and 7.6 h. In contrast, in the case of malvidin-3-glucoside this variability was much lower with half-life values between 1 and 2.8 h.
Urinary excretion profiles of the anthocyanins and their metabolites
After ingestion of the enocyanin containing the five anthocyanidin glucosides, urinary excretion of the different metabolites was monitored for 24 h by HPLC-DAD-MS analysis. Cyanidin-3-glucoside was the only anthocyanin that could not be quantified in urine even though it was detected in the urine of all seven subjects. Clear differences were shown in the excretion profile of anthocyanins. For instance, from the seven subjects in this study, two excreted most of the anthocyanins in their intact forms, as glucosides (87.1 ± 0.08 %). Two other participants in the study excreted 28.6 ± 3.8 % as glucuronides and only one of the subjects eliminated up to 50 % of the anthocyanins in urine as glucuronide.
Moreover, differences were shown in the form in which the monoglucosides of peonidin and malvidin were excreted in urine. In the case of the 24 hour excretion of peonidin-3-glucoside, 66 ± 25 % of it was in its conjugated form, whereas in the case of malvidin-3-glucoside only 32 ± 17 % was in its glucuronidated form.
Anthocyanins and their metabolites were rapidly eliminated in urine. In the first six hours after anthocyanin ingestion 94 ± 7 % of the total anthocyanins eliminated had been excreted ( figure 3 ). All the pigments quantified in the urine of the subjects had a period of maximum excretion of between 0 and 3 hours, with the exception of malvidin glucuronide which presented a slight delay in its period of maximum excretion, which was between 3 and 6 hours (49 ± 15 %). In this second period of time, between 3 and 6 hours, the elimination of peonidin glucuronide was also relatively high (43 ± 34 %).
Since malvidin-3-glucoside represented approximately 60% of the ingested anthocyanins, the possible existence of other metabolites derived from this anthocyanin was carefully analysed. Other metabolites such as the sulphates, diglucuronides, sulphates-glucuronides and malvidin aglycon were monitored by LC-MS in the SIM mode for each individual ion. However, none of these metabolites were detected in any of the urine samples analysed.
Antioxidant status
Most authors have described maximum effects in the increment of the antioxidant power of plasma after approximately one hour of the ingestion of red wine [16] [17] [18] . Given this, together with the fact that anthocyanidins reached their Previous work has demonstrated that red wine anthocyanins have an inhibitory effect on MCP-1 secretion in different endothelial cell models [7, [19] [20] .
Moreover, in a study carried out in rabbits ingesting a high cholesterol diet together with red wine for six weeks, a significant decrease in the expression of MCP-1 and its mRNA was shown [21] .
In this work the circulating levels of MCP-1 have been monitored throughout the 24 h study time at 0, 3, 6, 10 and 24 h after anthocyanin ingestion. Basal 19 circulating levels of MCP-1 were considered in the normal range for all the volunteers (165 ± 43 pg/mL). Figure 4 shows the relative changes of MCP-1 in plasma samples for all the volunteers in the study. Only at 3 h the decrease on the circulating levels of MCP-1 (96 ± 42 pg/mL) was statistically significant. After 24 h the levels of MCP-1 were again in the normal range (199 ± 118 pg/mL).
DISCUSSION
Anthocyanin absorption after a single dose of red grape extract is low (< 10 nmol/L) with a marked interindividual variation in the maximum concentration reached for total anthocyanins and individual metabolites. The maximum concentrations in plasma for glucosides and glucuronides were reached at 1.6 h and 2.5 h respectively.
Part of the inter-individual variation in the plasmatic levels of anthocyanin metabolites may be explained by biochemical factors such as differences in the expression or activity of enzymes involved in anthocyanin metabolism.
Glucuronidation is catalyzed by UDP-glucuronosyltransferases (UGTs). To date, more than 20 UGT isoforms have been described, showing differences in their regulation, substrate selectivity and tissue distribution. In the gastrointestinal tract, members of the UGT1A are mainly expressed, and among them UGT1A1 which presents a high allelic variability is considered to be responsible, at least partially, for the marked interindividual variation in the oral bioavailability of a number of drugs [22] . Furthermore it is likely that this genetic polymorphism makes a 20 significant change in the rate of malvidin conjugation with glucuronic acid and its subsequent metabolism.
The fact that the AUC for peonidin is three times higher than that of malvidin could indicate that peonidin is more bioavailable than malvidin. On the other hand, peonidin in plasma may also come from the physiological metabolism of other anthocyanins. For instance, cyanidin-3-glucoside methylation in its 3' position would produce a peonidin-3-glucoside molecule. This interconversion has already being described by other authors in human studies [23] [24] . However the marked differences between malvidin and peonidin AUCs may not be fully explained by this interconversion since the amount of cyanidin present in the anthocyanin extract was very low. Therefore, these differences in bioavailability of individual pigments indicates that the anthocyanin structure influences absorption, as has already being described for the petunidin, delphinidin and malvidin galactosides [25] and pelargonidin and cyanidin glucosides [24] .
Total anthocyanins excreted in urine represented 0.05 % of the ingested amount. From this excreted amount, 72.4 ± 13.6 % was in its intact glucosylated form and 27.6 ± 13.4 % in its glucuronidated form. No data on the glucuronidation rate of peonidin and malvidin has been published so far.
However, Felgines et al. [26] have reported an 80% excretion of pelargonidin-3-glucoside in its glucuronidated form. After consumption of different glycosides of cyanidin only 6 to 14 % [4, 27] were excreted in their glucuronidated forms.
These data may indicate that the process of conjugation with glucuronic acid 21 could be conditioned by the anthocyanidin structure. For this reason, pelargonidin, with only one hydroxyl group in the B-ring would impede to a lesser degree its conjugation with glucuronic acid than cyanidin, with two hydroxyl groups.
Even if we could not detect any malvidin glucuronides in the urine or plasma of some of the subjects in this study, it should be noted that the glucuronide conjugate of peonidin was found in every subject, both in plasma and urine.
Moreover, the levels of peonidin glucuronide were higher for longer than malvidin glucuronide despite the fact that the 12 g extract provided doses of peonidin approximately 7-fold lower than malvidin. This could be explained by the structural differences of the two anthocyanins, which may have an influence 
